IAPP and type 2 diabetes mellitus: In 1986 and 1987, Westermarket al. and Cooper et al. identified IAPP (also designated as Amylin) asthe major component of pancreatic amyloid deposits, a characteristic pathologicalfeature of type II diabetes [5, 6].